Get ahead in your career - track and evidence all your medical learning

Systemic lupus erythematosus: oral mycophenolate | Key-points-from-the-evidence | Advice | NICE

Evidence from a Cochrane review of randomised controlled trials (RCTs) and quasi-RCTs suggests that mycophenolate mofetil is as effective as cyclophosphamide at inducing remission in lupus nephritis, but with a lower risk of ovarian failure. For maintenance therapy in lupus nephritis the Cochrane...
Shared on Wednesday 28th October 2015


Asra Alwandi
Medical Student - St. Georges University, London
Posted about 4 years ago
Thank you for uploading the NICE guidelines. Very useful indeed.